CDKN2A and chronic kidney disease: Other senescence markers such as higher expression of senescence‐associated β‐galactosidase (SA‐β‐gal) and p16Ink4a and lower expression of cyclin D1 and cyclin‐dependent kinase 4 (CDK4) also confirmed cellular senescence in CKD MSCs (Figure 1f–i).